Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer

Clinical trial NCT03959397 · UNKNOWN

Trial details

NCT number: NCT03959397
Sponsor: Jilin University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Stage

Start date: 2019-06-01
Primary completion: 2021-06-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.